Yayınlar & Eserler

Yayın Ağı
Makaleler 77
Tümü (77)
SCI-E, SSCI, AHCI (63)
SCI-E, SSCI, AHCI, ESCI (76)
ESCI (13)
Scopus (75)
TRDizin (11)

1. Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes

Yıldız A., AHMED M. A., Eren N. N., AZİZY A., ARTAN S., ÇOKGEZER S., et al.
Nutrients , cilt.18, sa.7, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

2. Prognostic Role of Endocan and Platelet-Derived Growth Factor Isoforms in Metastatic Colorectal Cancer

Yildiz A., Ahmed M. A., Azizy A., Çokgezer S., Ulufer B., Soydinc H., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.27, sa.6, 2026 (SCI-Expanded, Scopus) identifier identifier

3. Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma

Harbi E., Byrne Y. Y., BOZBEY H. U., TAŞTEKİN D., Oncul O., Hosseiny S., et al.
Apoptosis , cilt.31, sa.2, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

4. Evaluating Comorbidity Scores in Geriatric Ovarian Cancer: A Retrospective Cohort Analysis

ÇOKGEZER S., AK N., Senkal M., Safaraliyeva A., TAŞTEKİN D., SAİP P. M.
Medicina (Lithuania) , cilt.62, sa.1, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

5. IGF Pathway Components as Potential Biomarkers in Gastric Cancer

CEYLANER B., ŞAHİN F., YILDIZ A., TAŞTEKİN D., GÖK A. F. K., BAYKAL A. T.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.22, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

6. A Pilot Study of Exploring miRNA-Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis

Şen S., Özgel M. Ç., Tunçer Ş. B., Bozbey H. U., Karabulut S., Taştekin D.
DIAGNOSTICS , cilt.15, sa.19, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model

Monfaredan A., Şen S., Fathi N. K., Taştekin D., Hosseininasab A., Bozbey H. U., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.17, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model

Monfaredan A., ŞEN S., Hosseininasab A., TAŞTEKİN D., Fazli G., Bozbey H. U., et al.
CANCERS , cilt.17, sa.10, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

9. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study

DEMİRCİ N. S., AZİZY A., Paksoy N., Doǧan I., KARABULUT S., Karahan L., et al.
Medicine (United States) , cilt.103, sa.9, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

10. Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer

KARABULUT S., ŞEN S., OĞUZ SOYDİNÇ H., Dogan I., TAŞTEKİN D., Karabulut M., et al.
PATHOLOGY RESEARCH AND PRACTICE , cilt.254, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey.

Karabulut S., Afsar C. U., Khanmammadov N., Karahan L., Paksoy N., Dogan I., et al.
Journal of cancer research and therapeutics , 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

12. Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?

Karabulut S., Afsar C. U., Paksoy N., Ferhatoglu F., Dogan I., Tastekin D.
Journal of cancer research and therapeutics , 2024 (SCI-Expanded, Scopus) identifier

13. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

KÖSTEK O., Demirel A., Hacıoğlu M. B., TAŞTEKİN D., KARABULUT S., Gündogdu A., et al.
Journal of Chemotherapy , cilt.36, sa.7, ss.613-621, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

14. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.
The oncologist , cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

15. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study

Senyurek S., Saglam S., Saglam E. K., Yanar H. T., Gok K., TAŞTEKİN D., et al.
ONCOLOGY RESEARCH , cilt.31, sa.5, ss.689-696, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience

TAŞTEKİN D., Paksoy N., DOĞAN İ., Ferhatoglu F., KHANMAMMADOV N., Bozbey H. U., et al.
Journal of cancer research and therapeutics , cilt.19, sa.2, ss.253-258, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

17. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Erol C., Nahit Sendur M. A., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.
Journal of cancer research and therapeutics , cilt.18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

18. Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma

Yalcinkaya B., Tastekin D., Guezelbulut F., Akgoz M., PENÇE S.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.68, sa.9, ss.1161-1165, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

19. Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study

Paksoy N., Ferhatoglu F., DOĞAN İ., Khanmammadov N., Bozbey H. U., KARABULUT S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, sa.4, ss.478-483, 2022 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

20. Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers

Karabulut S., Topalgokceli M. S., Tastekin D.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.6, sa.1, ss.12-15, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

21. Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study

Karabulut S., Dogan I., Usul Afsar C., Karabulut M., Karaman S., Ferhatoglu F., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.6, ss.1357-1363, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

22. WHAT'S NEW IN METASTATIC COLON CANCER TREATMENT?

Karabulut S., Karabulut M., Tastekin D.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.84, sa.3, ss.425-429, 2021 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier

23. Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Dogan I., Tastekin D., Karabulut S., Sakar B.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded, Scopus) identifier

24. Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Yalcinkaya B., Guzel Tanoglu E., Tastekin D., Pence S.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.638-643, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier identifier

25. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Hacioglu M. B., Kostek O., Karabulut S., Tastekin D., SEZGİN GÖKSU S., Alandag C., et al.
JOURNAL OF BUON , cilt.25, sa.4, ss.1897-1903, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

26. Examination of the expression levels of MACC1, Filamin A and FBXW7 genes in colorectal cancer patients

Yesilkaya F., Tastekin D., Al Saadoni H., Ergen A., Pence S.
NORTHERN CLINICS OF ISTANBUL , cilt.7, sa.1, ss.1-5, 2020 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier

27. Investigation of JAM-A (rs790056) and LFA-1 (rs8058823) gene variants in Turkish colorectal cancer patients

Caykara B., Alsaadoni H., Pence H. H., Pence S., Aydogan H., Tastekin D.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.10, ss.872-876, 2019 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier identifier

28. ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE

Bademler S., Ucuncu W. Z., Sari M., Yasasever C., Afsar C. U., Tastekin D.
ACTA MEDICA MEDITERRANEA , cilt.35, sa.1, ss.71-75, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

29. The Association of Pancreatic Cancer and PALB2 Gene Mutations in the Turkish Population

Turkcan G. K., Odemis D., Avsar M., Tuncer S. B., Erciyas S., Erdogan Ö., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.34, sa.4, ss.283-290, 2019 (ESCI, Scopus, TRDizin) identifier identifier

30. Evaluation of JAM-A (rs790056) and LFA-1 (rs8058823) Variants in Colorectal Cancer

Caykara B., Alsaadoni H., PENÇE H. H., Pence S., Aydogan H., Tastekin D.
ACTA PHYSIOLOGICA , cilt.225, ss.25, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

31. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.

Gurdal N., Fayda M., ALISHEV N., Bakir B., Tastekin D., Aykan F., et al.
Tumori , cilt.104, ss.266-272, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

32. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, sa.3, ss.578-582, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

33. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., Tastekin D., Akyol M., et al.
CLINICAL COLORECTAL CANCER , cilt.16, sa.3, ss.220-227, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

34. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., TAŞTEKİN D., Akyol M., et al.
JOURNAL OF BUON , cilt.21, sa.5, ss.1242-1249, 2016 (SCI-Expanded, Scopus) identifier

35. Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Kiziltan H. S., TAŞTEKİN D., ERİŞ A. H., Taspinar O., Ismaylova M., MAYADAĞLI A.
BEZMIALEM SCIENCE , cilt.4, sa.2, ss.51-55, 2016 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier

36. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.

Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.
Journal of gastrointestinal cancer , cilt.47, ss.182-6, 2016 (Scopus) Sürdürülebilir Kalkınma identifier identifier

37. Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS , cilt.4, sa.5, ss.609-614, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

38. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome

Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.
MOLECULAR AND CLINICAL ONCOLOGY , cilt.4, sa.4, ss.655-659, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

39. Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.
BIOMEDICAL REPORTS , cilt.4, sa.4, ss.485-488, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

40. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients

Tas F., Karabulut S., Tastekin D., Duranyildiz D.
BIOMEDICAL REPORTS , cilt.4, sa.4, ss.489-492, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

41. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.
BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.86-91, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

42. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.
BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.27-29, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

43. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer

Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.
European Review for Medical and Pharmacological Sciences , cilt.20, sa.2, ss.243-249, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

44. The relationship of beck depression inventory with vitamin D levels and visceral fat mass in cancer patients

Tuna S., Mert M., Soyluk O., Okuturlar Y., Kocoglu H., Tastekin D.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.5, ss.8719-8724, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

45. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.
TUMOR BIOLOGY , cilt.37, sa.1, ss.405-412, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

46. Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.
Experimental oncology , cilt.37, ss.218-22, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

47. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment

Tezcan Y., Surmeli M., Tastekin D., Koc M.
ARCHIVES OF IRANIAN MEDICINE , cilt.18, sa.9, ss.606-607, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

48. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

Turan N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.
CHINESE JOURNAL OF CANCER RESEARCH , cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

49. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.36, sa.3, ss.2097-103, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

50. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer

Arslan D., Tural D., Koca T., Tastekin D., Cerkesli A. K., Basaran H., et al.
JOURNAL OF BUON , cilt.20, sa.2, ss.573-579, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

51. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
BIOMEDICINE & PHARMACOTHERAPY , cilt.70, ss.19-23, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

52. Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients

Bal O., Arslan U. Y., Durnali A., Uyetrk U., Demirci A., Tastekin D., et al.
JOURNAL OF BUON , cilt.20, sa.1, ss.28-34, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

53. Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report

KIZILTAN H. Ş., GÜNEŞ BAYIR A., Taspinar O., Yucesan G., Tastekin D., Sonmez F. C., et al.
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE , cilt.21, ss.68-72, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

54. The Effects of Topical Insulin Application on Wound Healing

Kargin S., Tastekin D., Kilic K., Cezik A., Cakir M., Kucukkartallar T., et al.
EUROPEAN JOURNAL OF GENERAL MEDICINE , cilt.12, sa.4, ss.302-306, 2015 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

55. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.
Biomedicine and Pharmacotherapy , cilt.69, ss.237-241, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

56. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation

Tatli A. M., Urakci Z., Kalender M. E., Arslan H., TAŞTEKİN D., Kaplan M. A.
Asian Pacific Journal of Cancer Prevention , cilt.16, sa.5, ss.2003-2007, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

57. The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity

Tastekin D., Tambas M., KILIC K., Erturk K., ARSLAN D.
INVESTIGATIONAL NEW DRUGS , cilt.32, sa.6, ss.1295-1300, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

58. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients

Tastekin D., Kargin S., KARABULUT M., Yaldiz N., Tambas M., Gurdal N., et al.
TUMOR BIOLOGY , cilt.35, sa.12, ss.11871-11877, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

59. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.
MELANOMA RESEARCH , cilt.24, sa.5, ss.475-479, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

60. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.
TUMOR BIOLOGY , cilt.35, sa.9, ss.9303-9309, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

61. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.
TUMOR BIOLOGY , cilt.35, sa.9, ss.8849-8860, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

62. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

TURAN N., Benekli M., DANE F., Unal O. U., Kara H. V., KOCA D., et al.
Thoracic cancer , cilt.5, sa.5, ss.398-404, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

63. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.
TUMOR BIOLOGY , cilt.35, sa.7, ss.6777-6782, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

64. Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.
TUMOR BIOLOGY , cilt.35, sa.7, ss.6619-6625, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

65. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology

Uyeturk U., Oksuzoglu B., Akman T., Turker I., Sener N., Tastekin D., et al.
MEDICAL ONCOLOGY , cilt.31, sa.4, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

66. Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age <= 35)

Goksu S. S., Tastekin D., Arslan D., Gunduz S., TATLI A. M., Unal D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.16, ss.6665-6668, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

67. Impact of Poster Presentations on Academic Knowledge Transfer from the Oncologist Perspective in Turkey

Arslan D., Koca T., Tastekin D., Basaran H., Bozcuk H.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.18, ss.7707-7711, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

68. Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

KIZILTAN H. Ş., Bayir A. G., Tastekin D., ÇOBAN G., Eris A. H., AYDIN T., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.20, ss.8591-8594, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

69. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.18, sa.4, ss.273-278, 2014 (ESCI, Scopus) identifier identifier identifier

70. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.
TUMOR BIOLOGY , cilt.34, sa.6, ss.3529-3536, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

71. Rectal cancer in pregnancy: a case report and review of the literature.

Dogan N., Tastekin D., Kerimoglu O., Pekin A., Celik C.
Journal of gastrointestinal cancer , cilt.44, ss.354-6, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

72. Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology

Berk V., Kaplan M. A., Tonyali O., Buyukberber S., Balakan O., ÖZKAN M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.12, ss.7367-7369, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

73. The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

Hanci V., Kerimoğlu A., Koca K., Başkesen A., Kiliç K., Taştekin D.
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES , cilt.16, ss.15-21, 2010 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

74. [The opinions of Turkish physicians about the tasks of tuberculosis central dispensary].

Tanrikulu A., Palanci Y., Eren D., Yilmaz G., Karaca M., Abakay A., et al.
Tuberkuloz ve toraks , cilt.57, ss.32-7, 2009 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

75. Correlation between the erythrocyte sedimentation rate and blood nitric oxide levels in rabbits?

Uzun M., Saral S., Atakisi O., Yapar K., Uzlu E., Citil M., et al.
Scandinavian Journal of Laboratory Animal Science , cilt.35, sa.1, ss.53-56, 2008 (SCI-Expanded, Scopus) identifier identifier

76. Investigation of free radical scavenging enzyme activities and lipid peroxidation in liver tissue of zinc deficient rats

Kaya H., Taysi S., Kaya A., Boyuk A., DURSUN H., Islamoglu Y., et al.
Asian Journal of Chemistry , cilt.20, sa.2, ss.1068-1074, 2008 (SCI-Expanded, Scopus) identifier identifier

77. Hypoglycaemic effect of Artemisia herba-alba in experimental hyperglycaemic rats

Taştekin D., ATASEVER M., Adigüzel G., Keleş M., Taştekin A.
Bulletin of the Veterinary Institute in Pulawy , cilt.50, sa.2, ss.235-238, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

1. PANKREAS KANSERLİ HASTALARIN PERiFERİK KANINDA EPS8 VE KANK1 GEN EKSPRESYONLARININ İNCELENMESİ

ÖZGEL M. Ç., AKDENİZ ÖDEMİŞ D., TUNÇER Ş. B., TAŞTEKİN D., YAZICI H.
9. uluslararası beslenme obezite ve toplum sağlığı kongresi, 28 - 29 Ekim 2023, (Özet Bildiri)

2. Trastuzumab-based treatment of HER2-positive metastatic gastric cancer

Dogan I., Karabulut S., Tastekin D., Paksoy N., Sakar B., Vatansever S.
ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

3. The frequencies and prognostic significance of ABO blood and rhesus (D) groups in HER2-positive gastric cancer

Dogan I., Gurbuz M., Aydin E., Tastekin D., Karabulut S., Utkan G.
ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

4. Does nutritional status affect treatment tolarability, response, and survival in metastatic colorectal cancer patients? Results of prospective multicenter study

Karabulut S., Dogan I., Afsar C. U., Karabulut M., Karaman S., Ferhatoglu F., et al.
Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

5. Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.
3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

6. Rektum Kanserinde Neoadj. Sıb-Vmat Yanıtının Difüzyon Mr Ve Serum Apoptoz Marker Düzeyleri İle Değerlendirilmesi

GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.
12.Ulusal Radyasyon Onkolojisi Kongresi 20-24 Nisan 2016 Antalya, Antalya, Türkiye, 20 Nisan 2016, (Özet Bildiri)

7. Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi

GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.
12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2016, ss.45, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

8. Nüks meme kanserinde reoperatif sentinel lenf nodu biyopsisi: Aksilla korunabilir mi?

Karanlık H., Özgür İ., Kılıç B., Şanlı Y., Önder S., Taştekin D., et al.
13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Türkiye, 21 - 25 Ekim 2015, ss.1, (Özet Bildiri) Sürdürülebilir Kalkınma

9. The role of adhesion molecules in hepatocellulary carcinoma

Tastekin D., DIKILITAS M., HARPUTLUOGLU H., Erturk K., CELEBI K., Sen F., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) identifier

10. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

Turan N., Araz M., Algin E., Unal O. U., Benekli M., Tastekin D., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) identifier

11. Serum Hepatosit Büyüme Faktörünün Akciğer Kanserli Hastalarda Tanısal Değeri

ŞEN F., BOZBEY H., ÇİFTÇİ R., KILIÇ L., YILDIZ İ., TAŞTEKİN D., et al.
21. Ulusal Kanser Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

12. Hepatosellüler karsinomda galektin-3 ve fibronektin molekülleri yeni bir tümör belirteci olabilir mi?

SERİLMEZ M., AKYÜZ M., TAŞTEKİN D., OĞUZ SOYDİNÇ H., DURANYILDIZ D.
21. Ulusal Kanser Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.1, (Tam Metin Bildiri)

13. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

14. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) cud vascular cell adhesion molecule-1 (VCAM-1) levels in lung cancer.

KARABULUT S., Tastekin D., CIFTCI R., Tambas M., DAGOGLU N., Guveil M. E., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

15. Clinical significance of serum caveolin-1 levels in melanoma.

Tastekin D., KARABULUT S., DURANYILDIZ D., Tas F.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) identifier

16. Metastatik rektum kanseri olgularında kısa dönem radyoterapinin katkısı

İBİŞ K., ÖZKURT S., DAĞOĞLU SAKİN R. N., KAYTAN SAĞLAM E., TAŞTEKİN D., KESKİN M., et al.
11. Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 23 Nisan 2014, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Nazal Kavite Kaynaklı Tipik Karsinoid Tümör: Olgu sunumu

Gürdal N., Taştekin D., Güveli M. E., Özkaya K., Meral R., Altun M.
11. Ulusal Radyasyon Onkolojisi Kongresi, 23-27 Nisan 2014 ANTALYA, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.170, (Özet Bildiri)

18. Platin dirençli nüks eden baş boyun tümörlerinde setuximabın rolü, olgu değerlendirmesi

Karabulut S., Ekenel M., Tambaş M., Taştekin D., Altun M., Meral R., et al.
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.363, (Tam Metin Bildiri)

19. The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

Cetin B., TAŞTEKİN D., Aktas B., Guler T., Kaplan M. A., Berk V., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri) identifier

20. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Ciftci R., Karabulut S., Tastekin D., Sen F., Kilic L., Yildiz I., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri) identifier

21. Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

Karabulut S., Kilic L., Ciftci R., Yildiz I., Sen F., Keskin S., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

22. Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

Ciftci R., Keskin S., Karabulut S., Yildiz I., Kilic L., Sen F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) identifier

23. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Turan N., Dane F., Unal O. U., Benekli M., Kara H. V., Koca D., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma identifier
Kitaplar 2

1. High-Dose Vitamin C Is an Unorthodox Approach to Cancer Treatment

Şen S., Ugar M., Bozbey H. U., Taştekin D.
Original Research and Reviews in the Field of Medical Oncology, selim güngör, Editör, Platanus Publishing, Ankara, ss.5-44, 2024

2. The Role of Extracellular Vesicles in Drug Resistance and Treatment of Metastatic Cancers

Şen S., Taştekin D.
Original Research and Reviews in the Field of Medical Oncology, Selim Güngör, Editör, Platanus Publishing, Ankara, ss.45-72, 2024
Metrikler

Yayın

102

Yayın (WoS)

89

Yayın (Scopus)

75

Atıf (WoS)

532

H-İndeks (WoS)

15

Atıf (Scopus)

623

H-İndeks (Scopus)

16

Atıf (Scholar)

440

H-İndeks (Scholar)

14

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

5

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları